Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis

Kidney International

Volumn 86, Issue 2, 2014, Pages 423-432

  Den Hoedt, Claire H ^a,b   Bots, Michiel L ^b   Grooteman, Muriel P C ^c,d   Van Der Weerd, Neelke C ^e   Mazairac, Albert H A ^b   Penne, E Lars ^c   Levesque, Renée ^f   Ter Wee, Piet M ^c,d   Nubé, Menso J ^c,d   Blankestijn, Peter J ^b   Van Den Dorpel, Marinus A ^a  

^a Maasstad Hospital Rotterdam   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF MONTREAL   (Canada)

Author keywords

hemodiafiltration; hemodialysis; inflammation

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 6; IL6 PROTEIN, HUMAN; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; DISEASE MARKER; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LONG TERM CARE; LOW FLUX HEMODIALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMIC DISEASE; THERAPY EFFECT; TREATMENT OUTCOME; VASCULAR ACCESS; ADVERSE EFFECTS; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RENAL REPLACEMENT THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84905504041     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.9     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
2. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease-what have we learned in 10 years? Semin Dial 2010; 23: 498-509.
3. Zoccali C, Tripepi G, Mallamaci F. Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 2006; 17: S169-S173.
4. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16(Suppl 1): S83-S88.
5. Bazeley J, Bieber B, Li Y et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 2452-2461.
6. Carrero JJ, Yilmaz MI, Lindholm B, Stenvinkel P. Cytokine dysregulation in chronic kidney disease: how can we treat it? Blood Purif 2008; 26: 291-299.
7. Penne EL, Visser L, van den Dorpel MA et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int 2009; 76: 665-672.
8. Canaud B, Bosc JY, Leray-Moragues H et al. On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000; 15(Suppl 1): 60-67.
9. Panichi V, Rizza GM, Paoletti S et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008; 23: 2337-2343.
10. Vilar E, Fry AC, Wellsted D et al. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol 2009; 4: 1944-1953.
11. Panichi V, Manca-Rizza G, Paoletti S et al. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial. Nephrol Dial Transplant 2006; 21: 756-762.
12. Vaslaki L, Major L, Berta K et al. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006; 24: 163-173.
13. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 2007; 12: 26-33.
14. Filiopoulos V, Hadjiyannakos D, Metaxaki P et al. Inflammation and oxidative stress in patients on hemodiafiltration. Am J Nephrol 2008; 28: 949-957.
15. Oates T, Pinney JH, Davenport A. Haemodiafiltration versus high-flux haemodialysis: effects on phosphate control and erythropoietin response. Am J Nephrol 2011; 33: 70-75.
16. Vaslaki LR, Berta K, Major L et al. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study. Artif Organs 2005; 29: 406-412.
17. Carracedo J, Merino A, Nogueras S et al. On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol 2006; 17: 2315-2321.
18. Kuo HL, Chou CY, Liu YL et al. Reduction of pro-inflammatory cytokines through hemodiafiltration. Ren Fail 2008; 30: 796-800.
19. Tiranathanagul K, Praditpornsilpa K, Katavetin P et al. On-line hemodiafiltration in Southeast Asia: a three-year prospective study of a single center. Ther Apher Dial 2009; 13: 56-62.
20. Pedrini LA, Cozzi G, Faranna P et al. Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss. Kidney Int 2006; 69: 573-579.
21. Krieter DH, Hackl A, Rodriguez A et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010; 25: 212-218.
22. Meert N, Eloot S, Schepers E et al. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 2011; 26: 2624-2630.
23. Wizemann V, Lotz C, Techert F, Uthoff S. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000; 15(Suppl 1): 43-48.
24. Penne EL, Blankestijn PJ, Bots ML et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients - the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 2005; 6: 8.
25. Pedrini LA, De Cristofaro V, Comelli M et al. Long-term effects of highefficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 2011; 26: 2617-2624.
26. Ok E, Asci G, Toz H et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013; 28: 192-202.
27. Maduell F, Moreso F, Pons M et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24: 487-497.
28. van Tellingen A, Grooteman MP, Schoorl M et al. Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 2002; 62: 632-638.
29. Penne EL, van der Weerd NC, Blankestijn PJ et al. Role of residual kidney function and convective volume on change in beta2- microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 2010; 5: 80-86.
30. Rocco MV, Dwyer JT, Larive B et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65: 2321-2334.
31. Kaysen GA, Dubin JA, Muller HG et al. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 2004; 65: 1408-1415.
32. Kotanko P, Thijssen S, Usvyat L et al. Temporal evolution of clinical parameters before death in dialysis patients: a new concept. Blood Purif 2009; 27: 38-47.
33. Grooteman MP, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-1096.
34. Clase CM, Pierre MW St, Churchill DN. Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 2001; 16: 1925-1929.